SPY317.59+3.21 1.02%
DIA260.82+3.58 1.39%
IXIC10,617.44+69.69 0.66%
News
APTX
--
0.00%
--
Aptinyx to Host PTSD-Focused R&D Day on August 5th, 2020
Business Wire · 4d ago
Aptinyx to host PTSD-focused R&D day on August 5
Seeking Alpha - Article · 4d ago
Are Insiders Buying Aptinyx Inc. (NASDAQ:APTX) Stock?
Simply Wall St. · 5d ago
Were Hedge Funds Right About Warming Up To Aptinyx Inc. (APTX)?
Insider Monkey · 6d ago
The Daily Biotech Pulse: Novartis Settles Lawsuit For $678M, Sarepta In-Licenses Gene Therapy Pre-Treatment, Unity Biotech Outlines Second-Half Catalysts
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 1)
Benzinga · 07/02 12:21
Aptinyx to be Added to Russell 2000® Index
Business Wire · 06/26 13:37
Aptinyx To Be Added To Russell 2000 Index
Aptinyx to be Added to Russell 2000® Index Aptinyx Inc. (NASDAQ:APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, will be
Benzinga · 06/26 12:37
Aptinyx (APTX) Investor Presentation - Slideshow
Seeking Alpha - Article · 06/23 20:07
Week 26 MDA Breakout Forecast: Short-Term Picks To Give You An Edge
Seeking Alpha - Article · 06/21 10:52
Aptinyx PTSD Trial And Other News: The Good, Bad And Ugly Of Biopharma
Seeking Alpha - Article · 06/21 07:11
Aptinyx completes enrollment in mid-stage NYX-783 trial in PTSD
Seeking Alpha - Article · 06/18 13:15
Aptinyx Completes Enrollment In Phase 2 Exploratory Study Of NYX-783 In Post-Traumatic Stress Disorder
Benzinga · 06/18 11:58
Aptinyx Completes Enrollment in Phase 2 Exploratory Study of NYX-783 in Post-Traumatic Stress Disorder
Aptinyx Inc. (APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced the completion of enrollment in its ongoing Phase 2 exploratory study of NYX-783 to eva
GlobeNewswire · 06/18 11:57
Aptinyx to Present at Upcoming Virtual Investor Conferences
GlobeNewswire · 06/16 13:37
Is Aptinyx (APTX) Stock Outpacing Its Medical Peers This Year?
Is (APTX) Outperforming Other Medical Stocks This Year?
Zacks · 05/25 15:30
Week 22 MDA Breakout Forecast: Short-Term Picks To Give You An Edge
Seeking Alpha - Article · 05/24 08:21
Aptinyx Inc. (APTX) Moves to Strong Buy: Rationale Behind the Upgrade
Zacks · 05/20 17:00
Some Analysts Just Cut Their Aptinyx Inc. (NASDAQ:APTX) Estimates
Simply Wall St. · 05/20 13:49
Aptinyx's Shares March Higher, Can It Continue?
Zacks · 05/18 13:19
Aptinyx Inc. (NASDAQ:APTX) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
Simply Wall St. · 05/16 13:44